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The thymus supports T-cell development via specialized microenvironments that ensure a
diverse, functional and self-tolerant T-cell population. These microenvironments are
classically defined as distinct cortex and medulla regions that each contain specialized
subsets of stromal cells. Extensive research on thymic epithelial cells (TEC) within the
cortex and medulla has defined their essential roles during T-cell development.
Significantly, there are additional non-epithelial stromal cells (NES) that exist alongside
TEC within thymic microenvironments, including multiple subsets of mesenchymal and
endothelial cells. In contrast to our current understanding of TEC biology, the
developmental origins, lineage relationships, and functional properties, of NES remain
poorly understood. However, experimental evidence suggests these cells are important
for thymus function by either directly influencing T-cell development, or by indirectly
regulating TEC development and/or function. Here, we focus attention on the contribution
of NES to thymic microenvironments, including their phenotypic identification and
functional classification, and explore their impact on thymus function.
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The production of a diverse ab-T-cell pool is vital to establishing and maintaining a functional
adaptive immune system. While adult lymphoid progenitor cells are produced by the bone marrow,
their lineage commitment and development into mature T-cells is dependent on their migration
into the thymus, where essential interactions with heterogeneous thymic stromal cells take place (1).
Arguably, the most recognized and well-studied stromal populations in thymus biology are thymic
epithelial cells (TEC) within the cortical and medullary areas, which are defined by their anatomical
separation and function. Cortical epithelial cells (cTEC) support the earliest thymocyte progenitor
populations, guiding them through the cortex, directing them to a T-cell lineage fate and ensuring
their functional qualities as self-MHC restricted cells through the process of positive selection (2).
Medullary epithelial cells (mTEC), in conjunction with dendritic cells, then take over control of
developing thymocytes. Through the process of producing and presenting a diverse array of self-
antigens, mTEC drive single positive thymocytes either down conventional or Foxp3+ regulatory
thymocyte lineages (3). In addition, mTEC screen thymocytes for their expression of high affinity
ab-TCRs, with negative selection limiting the release of these reactive T-cells into the peripheral
pool (4). In addition to intrathymic selection, and during this medullary residency period, CD4+ and
CD8+ single positive (CD4SP, CD8SP) thymocytes acquire the ability to proliferate in response to
TCR stimulation, and undergo licensing for cytokine production, prior to exiting the thymus to joinorg February 2021 | Volume 12 | Article 6343671
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(5, 6). While many studies have demonstrated the importance of
cTEC and mTEC during T-cell development, thymic stromal
microenvironments also contain heterogenous non-epithelial
stromal (NES) populations in a similar manner to that seen
in peripheral lymphoid tissues. Broadly separated into
mesenchymal and endothelial cells, NES have been implicated
in thymus organogenesis, thymocyte development, tolerance
induction and development/maintenance of epithelial stroma.
As with TEC, our understanding of NES has been improved
through the phenotypic identification of new subpopulations,
such studies on thymic mesenchyme and endothelium have
provided new and important insight into their complexity and
functional importance. In this review, we cover how the non-
epithelial compartment of thymic stroma represent essential cell
populations in regulating thymus function.THYMIC MESENCHYME
Mesenchyme in Early Thymus
Development and Function
Organogenesis and Origin
In early experiments, physical separation of mesenchymal and
epithelial stroma from embryonic murine thymus resulted in
defective thymus development when epithelium was cultured in
vitro in the absence of mesenchyme (7). These findings were
confirmed in later studies in which removal of mesenchyme from
embryonic day 12 murine thymic lobes impaired thymus growth
in vitro (8). Furthermore, in ovo surgical ablation of cephalic
neural-crest mesenchyme resulted in significantly reduced
thymic size in fertile Arbor Acre chick embryos (9).
Collectively, these studies provided clear evidence that the
presence of mesenchymal stroma is key during the earliest
stages of thymus development, when the endodermal-derived
TEC rudiment is enveloped within and colonized by peri-thymic
neural crest (NC)-derived mesenchyme. Moreover, studies by
Jiang et al. (10) utilized Wnt1Cre mediated fate mapping models
to directly demonstrate the association of NC-derived
mesenchymal cells with the embryonic murine thymus.
Interestingly, although this study, and another by Yamazaki
et al. (11) using a myelin protein zero fate mapping model,
suggested that NC-derived mesenchymal cells could be scarcely
detected in the postnatal thymus, subsequent studies using
Wnt1Cre based models provided evidence that NC-derived
mesenchyme persists in adult thymic microenvironments (12,
13). Collectively, these findings in mammalian systems are
consistent with the studies by Bockman and Kirby (9) using
avian models that specifically pointed towards the importance of
cells of neural crest origin in early thymus development.
With regard to the mechanisms of thymic mesenchyme
function, their production of a number of growth factors has
been shown to influence TEC populations. For example, Revest
et al. discovered that fibroblast growth factor 7 (FGF7) and
FGF10 produced by thymic mesenchyme and their receptor
FGF-R2IIIb expressed by TEC were also essential for normalFrontiers in Immunology | www.frontiersin.org 2TEC development (14). In the absence of FGF-R2IIIb, thymus
development appeared arrested around embryonic day 12.5, and
the absence of either FGF-R2IIIb or FGF10 resulted in
hypoplastic thymi and reduced TEC proliferation (14). In later
studies, enzymatic removal of thymic mesenchyme was shown to
reduce TEC proliferation (15), which could be restored by the
addition of exogenous FGF7 and/or FGF10 in vitro. Interestingly,
this study also found that while mesenchyme and FGF7/10 are
essential for TEC proliferation, they are disposable for TEC
differentiation, with embryonic TEC acquiring cTEC and
mTEC phenotypes in the absence of mesenchyme and
importantly these epithelial cells are functionally mature (15).
Indeed, transplantation of embryonic day 12 thymus lobes
stripped of thymus mesenchyme remained small, but retained
the ability to support a complete program of T-cell development
(16). Such findings suggest that an important property of thymic
mesenchyme is to induce the proliferation of developing TEC in
order to provide increasing numbers of intrathymic niches to
support efficient T-cell development. In the absence of such
mesenchyme-derived signals, niche availability remains limited
and results in diminished T-cell production. In addition,
epidermal growth factor (EGF) has been suggested to be a
product potentially produced by thymic mesenchyme to
support TEC proliferation and thymus lobule formation, as
EGF can replace thymic mesenchyme in supporting TEC in
cultures (17). Similarly, insulin-like growth factor (IGF) has been
shown to be a mesenchyme product and IGF has been shown to
regulate TEC development, but it has not been directly shown
that mesenchymal-specific loss of either IGF or EGF leads to
TEC defects (16–18). Thus, thymic mesenchymal cells play an
important role in quantitatively regulating thymus function.
While several mesenchymal growth factors have been
implicated in this process (e.g., FGF7/10), further studies are
required to examine the distinct functional properties, and
cellular origins, of these molecules. Relevant to this, expression
of the transcription factor MafB by thymic mesenchyme was
shown to regulate production of Wnt3, Wnt11, and BMP4 which
regulate TEC function, including the production of chemokines
required for normal progenitor homing to the thymus (19).
Finally, as well as influencing the functional properties of
TEC, mesenchyme has also been shown to influence the
anatomic positioning of the thymus during its development.
Studies of Pax3Sp/Sp mice, which carry a point mutation in Pax3
eliminating protein function, revealed that separation of the
thymus from the pharynx, migration of the thymus to its
position at the mediastinum and distribution of the thymus:
parathyroid domains are dependent on the presence of thymic
mesenchyme (17, 20). The thymus of these mice was significantly
increased in size whereas the parathyroid was reduced and there
was a delay in the separation of the two as a result of
dysfunctional boundary formation between the thymus and
parathyroid domains (20). Interestingly, evidence also suggests
that a bi-directional relationship may exist between neural-
crest derived mesenchyme and endoderm, where epithelial-
derived FGF8 may regulate mesenchymal populations, where
FGF8 hypomorphs demonstrate ectopic thymus positioning andFebruary 2021 | Volume 12 | Article 634367
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expression of FGF10 (21).
Mesenchyme and T-Cell Development
Using the reaggregate thymic organ culture (RTOC) technique,
where defined thymocyte and stromal subsets can be
reassembled into 3-dimensional structures, studies provided
evidence that specific stages of thymocyte development are also
dependent on the presence of thymic mesenchyme (22, 23). For
example, culture of CD4−CD8− (DN) T-cell precursors in the
presence of TEC alone resulted in an absence of further T-cell
development. In contrast, the addition of mesenchymal cells
resulted in development to the CD4+CD8+ double positive (DP)
and CD4SP and CD8SP stages (23). Importantly, TEC alone
were able to support the development of CD4+CD8+ thymocytes
to the CD4SP and CD8SP stages, indicating that a stage-specific
requirement for mesenchyme operates at the DN-DP but not
DP-SP transition. Later, further analysis revealed that the
importance of thymic mesenchyme was specific to supporting
the development of CD25+CD44+ DN2 thymocytes, with
independence from mesenchyme occurring from the
CD25+CD44− DN3 stage (22). How thymic mesenchyme
influences specific stages of T-cell precursor development
remain unclear. However, it is interesting to note that this
requirement can be met by both mesenchyme cells of non-
thymic origin (eg embryonic lung) or fibroblast cell lines (eg
NIH-3T3) (23). Moreover, and as demonstrated for bone
marrow stroma (24), mesenchymal cells that regulate lymphoid
progenitor development are effective presenters of the key
cytokine IL7 via their production of extracellular matrix
components (22), suggesting a possible mechanism for their
involvement in early T-cell development. Importantly however,
it is important to note that studies on the regulation of T-cell
development by thymic mesenchyme are based largely on the
requirements for fetal lymphoid progenitors, and often involve
analysis of T-cell development using in vitro culture. As such,
further studies are required to assess whether similar
requirements operate in both the fetal thymus in vivo, and
whether DN T-cell precursors in the adult thymus are similarly
controlled by mesenchyme.
Mesenchyme in the Adult Thymus
Characterization
While initial studies suggested that NC-derived thymic
mesenchyme does not persist beyond the embryonic thymus
(10, 11), further studies utilizing NC specific Wnt1Cre and
Sox1Cre mouse models (crossed to Rosa26 reporter mice)
enabled identification of NC-derived mesenchymal cells within
adult thymus (12, 13). Here, thymic mesenchyme is located in
multiple places. It helps contribute to the structure of the thymus
lobe making up the capsule around the outside of the thymus (25,
26) and thymic mesenchyme has been reported in the cortex
(13), medulla (26) and as well as around blood vessels both
dispersed throughout the thymus, and at the corticomedullary
junction (CMJ) (27–29). In addition, Komada et al.
demonstrated that while NC-derived mesenchyme contributesFrontiers in Immunology | www.frontiersin.org 3to pervivascular cells, mesoderm-derived cells contribute to
endothelial compartments (30). Thus, mesenchymal cells are
present in the adult thymus at multiple sites where distinct stages
of T-cell development take place. In addition to anatomic
location, various phenotypic markers have been used to
identify thymic mesenchymal cells, and different studies have
used various marker combinations to define thymic
mesenchymal stroma and subsequent subpopulations.
Currently, a clear consensus on the panel of mesenchymal
markers to be used is lacking, and for markers that are used,
there is often overlap in cell populations that are studied. For
example, commonly used markers of thymic mesenchyme
include PDGFRa, PDGFRb, Ly51, Podoplanin (Pdpn, gp38)
MTS-15, ERTR7, and FSP1 (13, 16, 25, 27, 31–33). Pdpn is a
notable marker, as it is frequently used to identify thymic
mesenchyme and often stained alongside CD31 to distinguish
between endothelium and mesenchymal cells, an approach also
used in peripheral lymph nodes to identify the fibroblastic
reticular, lymphatic endothelial and blood endothelial cell
subsets (29, 34). Interestingly, in addition to being utilized as a
phenotypic marker of mesenchymal populations, Pdpn may
potentially play functional roles in the thymus. For example,
Pdpn has been proposed to contribute to CCL21 localization in
thymic microenvironments and contribute to the development
of regulatory T cells in young mice (35). It is important to note
that while Pdpn and CD31 expression can highlight some
similarities in the populations of non-epithelial stroma, unlike
peripheral secondary lymphoid tissues where a clear lymphatic
stromal population is present, the presence/absence of
lymphatics within the thymus has been difficult to resolve.
Previous confocal analysis of the thymus to detect expression
of VEGFR3 and LYVE-1 suggested the presence of lymphatic
vessels (25). Using Lyve-1Cre–mediated fate mapping, or dual
analysis of CD31/Pdpn expression by flow cytometry, lymphatics
were extremely rare and difficult to observe (29). Use of Lyve1Cre
to target any potential lymphatic population within the thymus is
complicated by the observation that this approach labels a
significant proportion of thymocytes when crossed to a
reporter model (36).
Recent phenotypic analysis of thymic mesenchyme from
Sitnik et al. revealed Pdpn+ and Pdpn− populations within
PDGFRb+ thymic mesenchyme in the adult thymus (27). The
inclusion of the additional markers CD34 and Itga7 was further
used to identify these two subsets as Pdpn+CD34+ adventitial
mesenchyme cells and Pdpn−Itga7+ thymic pericytes, where
adventitial mesenchyme surrounds pericytes which in turn
surround blood endothelium of vessels (27, 28). A recent
advancement has shown that the marker Dipeptidyl-peptidase
4 (DPP4) can be used to distinguish between capsule fibroblasts
(capFb, which are DPP4+) and medullary fibroblasts (mFb,
which are DPP4−), further characterizing the different
mesenchymal populations present in the adult thymus (26).
How these DPP4+ mesenchymal subsets relate to CD34+
adventitial and Itga7+ pericytes described previously is not
clear. Thus, follow up studies are important to examine how
various definitions of mesenchyme populations correlate withFebruary 2021 | Volume 12 | Article 634367
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heterogeneity that would allow effective analysis of thymic
mesenchyme function in the adult thymus.
Functional Roles of Adult Thymic
Mesenchyme
Regulation of Thymic Epithelial Cells
While mesenchymal cells regulate the proliferation of embryonic
TEC (14, 16), studies demonstrate that thymic mesenchyme can
also be a negative regulator of TEC expansion during
embryogenesis and that this property is maintained in the
adult thymus (32). Thus, thymic mesenchyme was identified as
a major intrathymic source of retinoic acid (RA) which was
found to restrict TEC proliferation, in particular within the cTEC
compartment (32). Interestingly, these same cells that produce
RA may also have the ability to produce growth factors such as
FGF7/10 that have a positive impact on TEC proliferation during
thymus organogenesis and perhaps have a continued role in the
adult thymus (14–16). Thus, thymic mesenchyme has the ability
to both positively and negatively regulate the TEC compartment
in the developing and adult steady-state thymus. Interestingly,
thymic mesenchymal cells from adult thymus have also been
shown to be capable of sphere-formation, a property initially
thought to define TEC stem cells. Thus, Sheridan et al. (37)
showed that thymosphere-forming cell (TSFC) represent long-
lived cells of mesenchymal origin which also possess progenitor-
like capacities, and are able to give rise to adipocytes (37). While,
the functional properties of sphere-forming mesenchymal cells
require further examination, evidence of a role for thymic
mesenchyme in regulating TEC subsets was reported in studies
where mesenchyme-specific deletion of LTbR was achieved using
Twist-2Cre mice (26). Here, deletion of LTbR on thymic
mesenchyme resulted in a number of intrathymic changes,
including reduced mTEC numbers in the adult thymus (26).
Whether this is indicative of mechanism where thymic
mesenchyme regulates TEC in the steady state adult thymus,
or rather relates to the role of mesenchyme regulating TEC
during thymus organogenesis requires further examination.
Similarly, thymic fibroblasts defined by Fibroblast specific
protein 1 (FSP1) expression appear to be an important
regulator of TEC populations (33). Indeed, FSP1+ mesenchyme
produce IL-6 and FGF7, and the absence of FSP1+ mesenchyme
results in a significantly smaller thymus size and reduced TEC
numbers (33). Interestingly, as well as being a useful phenotypic
marker, FSP1 itself may be an important molecular mediators of
adult thymus mesenchyme function, as addition of FSP1 to TEC
in culture significantly increases their proliferation and
expression of CD80 and AIRE (33).
Collectively, the studies above highlight how thymic
mesenchymal stroma supports the TEC compartment in the
adult thymus at steady state. Additionally, some findings also
implicate thymic mesenchyme in supporting TEC and thymus
recovery following damage. For example, Sun et al. found that
deleting FSP1+ thymic mesenchyme resulted in significantly
delayed regeneration in a cyclophosphamide-induced thymic
involution model (33). Gray et al. also found that uponFrontiers in Immunology | www.frontiersin.org 4cyclophosphamide-induced thymic involution, MTS-15+
thymic fibroblasts expanded during regeneration and produced
FGF7, FGF10 and IL-6 to promote TEC proliferation and
increase T-cell production (31). Interestingly Sun et al. found
that FSP1+ mesenchyme was distinct from MTS-15+ fibroblasts
thus demonstrating some conservation of function between the
two mesenchymal populations (31, 33). These are distinct from
MTS-15 expressing thymic mesenchyme as shown by FACs but
also by confocal showing these cells were localized in different
areas of the thymus (33). Finally, expression of CD248
(endosialin), a protein linked to remodeling of tissues, is
induced within PDGFRa+ thymic mesenchyme during
infection (38). In a Salmonella infection model, CD248-
deficient mice exhibited reduced thymus size and poor thymus
regeneration, indicating a specific but poorly understood role for
CD248 expression by mesenchyme in controlling the recovery of
thymus function following acute thymus atrophy (38).
Thymus Emigration
The microanatomical positioning of adventitial cells and
pericytes around blood vessels in adult thymus, suggest a
possible role in regulating the egress of mature thymocytes
from the thymus following their intrathymic development. The
sphingosine-1-phosphate (S1P) pathway has been shown to be a
key axis for the egress of mature thymocytes (29, 39, 40), with a
complex interplay of multiple cellular compartments, including
thymic mesenchymal cells being involved in this pathway.
Regulation of the S1P pathway centers on maintaining a low
gradient of S1P within the thymic parenchyma and restricting
availability to points of exit, via the production of S1P via kinases
and transporters, or the degradation of S1P (which can be by
reversible and non-reversible means) (41). The sphingosine
kinases SPHK1 and SPHK2 are essential regulators of S1P
production, where deletion of Sphk1 in NC-derived thymic
mesenchyme, using conditional Wnt1Cre mediated deletion,
disrupts thymocyte egress (29). Mature SP in the thymus of
these mice had elevated levels of S1PR1 expression that is
consistent with reduced exposure to available S1P. These
findings were accompanied by an intrathymic accumulation of
mature SP thymocytes, a phenotype highly indicative of an egress
defect (29). Mesenchyme can also influence the S1P gradient
through S1P lyase, an enzyme which irreversible cleaves S1P and
thus in the context of egress acts to maintain low intrathymic S1P
levels and ensure migration of mature thymocytes towards high
concentrations of S1P present in blood (39). Consistent with this
role, it has been shown that S1P lyase expression is focused
around blood vessels where it is expressed by thymic endothelial
cells as well as thymic mesenchyme (39). The importance of S1P
lyase in regulating egress was highlighted by the use of the S1P
lyase inhibitor 2-Acetyl-4-tetrahydroxybutylimidazole (THI),
which causes an intrathymic accumulation of mature SP
thymocytes and reduced T-cell output (39, 42). Based on the
location of its expression and its mode of action the authors
suggest that S1P lyase degrades S1P in the PVS irreversibly to
create a low S1P environment which again acts to promote the
egress of mature thymocytes (39).February 2021 | Volume 12 | Article 634367
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thymic egress through an additional pathway that includes the
chemokine receptor CCR7, a pathway previously shown to play
an important role in neonatal thymus egress (43, 44). We showed
that in the absence of both CCL21 and CCL19, thymic egress of
conventional SP thymocytes is impeded, with this requirement
specifically mapping to a non-redundant role of CCL21 but not
CCL19 (28). In the adult thymus it is known that CCL21 is
produced by an mTEC subset, as most recently shown through
the use of CCL21TdTom reporter mice (45). Interestingly, analysis
of CCL21 protein distribution in the neonatal thymus revealed
this was concentrated around blood vessels at the
corticomedullary junction (28). Further analysis revealed that
expression of heparin sulfate by CD34+ adventitial cells, and to a
slightly lesser extent expression by Itga7+ pericytes, regulated
CCL21 presentation by these mesenchymal populations found at
this site (28). Thus, while CCL21 is a product of mTEC, its
presentation is dependent on thymic mesenchymal populations
for neonatal thymic egress, highlighting the combined action of
epithelium and mesenchyme for regulation of a key process in
thymocyte development. It is important to note that the role of
CCL21 in egress is limited to the neonatal window, as adult
CCR7-deficient mice show no thymic egress defect (44, 46).
Thus, thymic mesenchymal regulation of thymocyte egress is
temporal and limited to the neonatal window and thus theFrontiers in Immunology | www.frontiersin.org 5earliest waves of ab thymocyte egress (28). The precise
differential impact of CCL21 on thymocyte emigration at
neonatal and adult stages remains unclear. Interestingly
however, previous studies have suggested potential differences
in the expression of the S1P receptor S1P1 in neonatal versus
adult SP thymocytes (47). Evidence from this study
demonstrated that neonatal thymocyte egress can be blocked
using FTY720 treatment, indicating that the S1P-axis is
functional in the window when S1P1 expression is low and
that CCL21 also regulates thymus egress, raising the interesting
notion that CCL21 may act to compensate for or facilitate
reduced S1P- axis activity in the perinatal period, with this
requirement being superseded by increased S1P1 expression at
adult stages.
Additional studies have further proposed that expression of
the lymphotoxin b receptor (LTbR) by specific thymic stromal
compartments, including mesenchyme, may regulate thymocyte
egress in the adult thymus. Germline LTbR deletion leads to an
intrathymic accumulation of mature thymocytes and reduced
recent thymic emigrants (RTE) being indicative of a thymic
egress defect (48, 49). In a Twist-2Cre x LtbrFlox mouse model,
where LTbR deletion is restricted to thymic mesenchyme, Nitta
et al. additionally noted an intrathymic accumulation of mature
SP thymocytes suggesting that the egress defect seen in germline
LTbR-deficient mice could potentially include a requirement forFIGURE 1 | Endothelial cells regulate T-cell progenitor entry. Initial steps in thymocyte development involve homing to, and colonizing of, the thymus by bone
marrow-derived blood-borne progenitors via blood vessels at the corticomedullary junction (orange dotted line). Entry of these progenitors is controlled by thymic
endothelial cells (EC) which regulate this process through a number of different mechanisms detailed in the inset figure (black dotted line/box). ECs express P-
selectin, the ligand for which (P-selectin glycoprotein ligand 1, PSGL-1) is expressed by lymphoid progenitor cells. P-selectin-PSGL1 interactions are essential in
slowing down progenitor movement, allowing them to interact with ICAM-1 and VCAM-1 expressed by ECs. In adult thymus, CCL25 (ligand for CCR9) which is
produced by both TEC and ECs has also been shown to be essential for progenitor homing to the thymus. Additionally, CCR7 is involved in thymus colonization,
although its precise ligand requirements (CCL19 and/or CCL21) is not known.February 2021 | Volume 12 | Article 634367
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numbers of SP thymocytes could be a consequence of reduced
negative-selection observed in these mice (26). In other models
a im ed a t d e l e t i o n o f LTbR f r om me s e n c h yme
(Wnt1Cre2xLTBRFlox), this SP thymocyte accumulation and
emigration defect was not observed. While the reasons for this
difference are not clear, it may be that while both Wnt1Cre2 and
Twist2Cre are active in thymic mesenchyme, the exact subsets
that are targeted differ. It will be important to formally define the
types of thymic mesenchyme that are targeted in specific Cre
expressing mouse strains in order to gain a clearer picture of the
role of individual mesenchyme subsets controlling T-
cell development.
Thymic Tolerance
In line with the abundance of mesenchymal stroma within
medullary areas, these cells have also been implicated in the
regulation of tolerance induction of developing thymocytes.
Interestingly this finding was perhaps born from attempts
to understand how signaling via LTbR within TEC
microenvironments influenced thymocyte development. First
described by Boehm et al., 2003, mice deficient for LTbR
exhibited a clear reduction in mTEC numbers, and severely
disrupted medullary organization (48). Instead of characteristic
large medullary areas surrounded by cortex, thymus from LTBR-
KO mice had an increased frequency of smaller medullas
dispersed throughout the organ (48, 50). These mice also
displayed intrathymic accumulations of mature SP thymocytes
indicating disrupted thymocyte egress, as well as autoimmune
symptoms including autoantibodies and lymphocytic infiltrates
into tissues (48, 50, 51).
Through the use of a panel of stromal-cell specific Cre mice
crossed to LTbRFlox mice, we examined the contribution of
epithelium, mesenchyme and endothelium to regulation of
LTbR-dependent tolerance induction in the thymus (50).
Deletion of Ltbr on TEC recapitulated the mTEC phenotype of
Ltbr−/−mice, but despite this, there was no autoimmune or T-cell
egress defect in these mice (50, 51). De novo Treg generation was
found to be independent of LTbR signaling and instead it
appeared that dendritic cells were also disrupted in the LTbR-
germline KO thymus (50). Screening of different stromal cell
specific Ltbr deletion models revealed that only when Ltbr is
deleted onWnt1Cre2-expressing thymic mesenchyme (LTbRMes),
identified as CD45−EpCAM-1−CD31−Pdpn+ by flow cytometry,
was the DC-defect of Ltbr−/− mice replicated and this pathway
was proposed as the mechanism by which LTbR signaling
regulates thymic tolerance (50). Further analysis of DC kinetics
revealed an essential role for CCR7 expression by DC and CCL21
production by thymus for development of Sirpa− conventional
DC type 1 (cDC1), a population significantly reduced in Ltbr−/−
and LTbRMes mice (52). Thus, it is interesting to speculate
whether the role of CCL21 presentation by thymic
mesenchyme is LTbR-dependent and the possible mechanism
that causes the tolerance breakdown in Ltbr−/− thymus.
Interestingly it has been shown that thymic DC can regulate
thymocyte egress via S1Plyase (53). However, LTbRMes mice,
utilizing the Wnt1Cre2 promotor, do not exhibit the egress defectFrontiers in Immunology | www.frontiersin.org 6seen in Ltbr−/− mice, suggesting that the LTbR-dependent
regulation of thymic DC is not essential for thymocyte egress
(50, 51).
Using Twist2CreLTbRFlox mice Nitta et al. showed that despite
no observed DC defect, there were increased auto-antibodies and
cellular infiltrates and this correlated with reduced numbers of
Pdpn+ thymic mesenchyme which lacked mFb-specific genes
including specific TRAs (26). They suggest that expression of
MHC Class I, in conjunction with evidence of protein handover/
pickup by thymic DC, work to support central tolerance
induction during thymocyte development and thus thymic
mesenchyme has a significantly more direct role in thymus
tolerance via self-Ag production rather than regulating DCs
(26). Interestingly, this pathway would appear to mirror that
proposed for regulation of peripheral tolerance by non-epithelial
fibroblastic reticular stromal cells in secondary lymphoid tissues
(54). The striking difference here between the two mesenchyme-
specific models for deleting Ltbr is that while there is a clear
DC defect in Wnt1Cre2LTbRFlox mice used in the Cosway et al.,
study there is no egress defect, whereas in the Twist2CreLTbRFlox
of the Nitta et al., study the reverse is true (26, 50). As the
Cre-lines used in each study appear faithful it remains difficult to
fully elucidate the exact role that LTbR and thymic mesenchyme
is playing in regulating thymic tolerance or thymic egress. A
follow up of Nitta et al. study to understand how their data of an
Ag presentation role of mFbs fits into the landscape of CD34+
adventitial and Itga7+ mesenchyme, and what further gene
expression differences exist within these mesenchyme
populations would be very interesting and useful to further our
understanding of the heterogenous populations and roles that
thymic mesenchyme in the adult thymus carry out.THYMIC ENDOTHELIUM
Regulation of Thymocyte Development
Thymus Colonization by Lymphoid Progenitors
The thymus does not contain a pool of self-renewing
hematopoietic stem cells and so relies on remote colonization
of bone-marrow derived progenitor cells from the blood into the
thymus. Thus, thymic endothelial cells play an essential role in
interacting with the T-cell progenitors in the blood to ensure
site-specific extravasation of progenitor cells into the thymus for
the ongoing production of T-cells (55) (Figure 1). During
development, thymus vascularization is evident around
embryonic day 15.5 (E15) (56), with CD31+ endothelial cells
abundant in thymus sections at E15.5, but not at earlier time
points (56–58). The dense 3-D vascular network present at this
stage was shown using an elegant approach in which intravenous
microinjections of resin into embryos was performed, with
subsequent digestion of tissues to leave a resin cast which was
then imaged using scanning electron microscopy (56). It is
interesting to note that T-cell progenitors colonize the thymus
at earlier time points prior to thymus vascularization. At earlier
stages (<E15) T-cell progenitors have to migrate through the
perithymic mesenchymal layer that invests the early epithelialFebruary 2021 | Volume 12 | Article 634367
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epithelial microenvironments (56, 59, 60). During this period the
CCR9 ligand CCL25 produced by Foxn-1–dependent thymic
primordium and the CCR7 ligand CCL21 produced by Gcm2-
dependent parathyroid, are essential in progenitor colonization
of the early thymus (56, 61, 62). CXCR4 also aids colonization of
the embryonic thymus, but the precise intrathymic cellular
source is not clear (63). Critically, the requirement for CCR7
and CCR9-dependent thymus colonization is maintained into
adulthood, where CCR7/CCR9 double deficient mice
(Ccr7−/−Ccr9−/−) demonstrate reduced thymus colonizing cells,
albeit such reductions are potentially made up for by subsequent
compensatory expansion of thymocytes (64).
A key endothelial mechanism that regulates T-cell progenitor
entry into the thymus is the interaction between endothelial
expressed P-selectin and P-selectin glycoprotein ligand 1 (PSGL-
1)–bearing progenitor (65–67). PSGL1-deficient thymi have
reduced numbers of ETP due to the reduced ability of
progenitor cells to enter the thymus (66). Parabiotic or
adoptive transfer experiments revealed clear evidence for the
essential role of P-selectin:PSGL1 interactions for progenitor
homing to the thymus (66, 67). Consistent with this, treating
cells with anti-P-selectin neutralizing antibody significantly
impaired progenitor homing to the thymus (67). This P-Frontiers in Immunology | www.frontiersin.org 7selectin/PSGL-1 interaction slows down progenitors allowing
them to interact with ICAM-1 and VCAM-1, whose expression
by the endothelium is also key in the process of progenitor
homing and entry into the thymus (67). In a related study,
Gossens et al. found that in addition to P-selectin, endothelial
production of CCL25 is also be a key regulator of T-cell
progenitor homing to the adult thymus (65). They found that
mouse models with T-cell progenitor intrinsic entry defects were
significantly more receptive to the homing and entry of WT T-
cells progenitors (65). This increased receptivity correlated with
increased P-selectin and CCL25 expression by thymic
endothelial cells, suggesting both are involved in T-cell
progenitor homing and colonization (65). Interestingly this
same study revealed that endothelial expression of P-selectin
and CCL25 is the mechanism by which endothelial cells enforce
the temporal, gated, nature of thymus colonization, wherein the
thymus goes through periods of receptiveness and non-
receptiveness to colonization by new T-cell progenitors (55, 65,
68). This phenomenon may be part of a process by which
progenitor niche availability within the thymus directly feeds
back and acts on the ability of progenitors to enter the thymus or
not (65, 69). Gossens et al. showed that progenitors act on the
endothelium to limit the expression/production of P-selectin and
CCL25, when the intrathymic population of progenitors isFIGURE 2 | Endothelial cells regulate mature thymocyte egress. Similar to progenitor entry into the thymus, egress of mature thymocytes that have completed their
intrathymic development occurs via blood vessels at the corticomedullary junction (orange hashed line). Mature CD4+CD8− (SP4) or CD4−CD8+ (SP8) thymocytes
which express the S1P receptor S1P1 migrate from the medulla to the CMJ to begin their exit from the thymus. As detailed in the inset figure (black dotted line/box),
mature SP thymocytes first enter the perivascular space (PVS) and then cross the endothelium into the blood via reverse transendothelial migration, with both
processes being S1P-dependent. Thymic ECs play an essential role in this process by maintaining the S1P gradient within the thymic parenchyma/PVS. ECs can
increase S1P levels through their expression of the S1P transporter Spinster homolog 2 (SPNS2) which transports S1P synthesized through the phosphorylation of
sphingosine by sphingosine kinase (SPHK). Conversely, ECs reduce S1P levels through expression of lipid phosphate phosphatase 3 (LPP3) which
dephosphorylates S1P to sphingosine or by irreversibly degrading S1P via S1P lyase. These mechanisms maintain the export of mature thymocytes essential to
contribute to the peripheral T-cell pool.February 2021 | Volume 12 | Article 634367
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are signaled to increased P-selectin and CCL25 (65). This then
drives increased progenitor entry, which fills the intrathymic
niches signaling endothelial cells to reduce their production of P-
selectin/CCL25 and the cycle continues (65). In line with this, P-
selectin and CCL25 expression levels correlated with phases of
thymic T-cell progenitor receptivity and non-receptivity (65).
Additionally, in mouse models which have a significant T-cell
progenitor reduction in the thymus and subsequently have
increased niche availability, these mice showed increased
expression of P-selectin and CCL25 and also increased
receptiveness to peripherally induced WT T-cell progenitors
(65). Therefore, not only do thymic endothelial cells regulate
the entry of progenitor cells by their expression of key molecules
such ICAM-1, VCAM-1, P-selectin and CCL25, but they act as
gatekeepers regulating the phases of entry and no-entry to new
progenitor cells by adjusting the amount and periodicity of their
expression of CCL25/P-selectin (65). The mechanism that
regulates these changes in expression of key genes is not clear.
However, an interesting study highlighted a key role for the
transcriptional regulator early growth response gene 1 (Egr1) as
part of a negative feedback loop in this system. Here, Schnell
et al. showed that Egr1-deficient mice had increased thymocyte
number as a direct result of increased T-cell progenitor homing
and interestingly Egr1 was expressed by DN thymocytes (70).
Correlating with increased progenitor homing, they found that
endothelial cells of Egr1-deficient thymus had increased P-
selectin expression, suggesting that Egr1 mediates a feedback
mechanism whereby the number of DN thymocytes controls the
entry of new T-cell progenitors by regulating P-selectin
expression by the thymic endothelium (70).
When T-cell progenitors enter the thymus via blood vessels, they
do so via large venules found at the corticomedullary junction
(CMJ), after which they migrate through the cortex towards the
subcapsular zone (SCZ) to begin the step-wise development
program within the thymus (71, 72). It has been shown that a
subset of endothelial cells appears enriched at the CMJ and such
cells play key roles in regulating T-cell progenitor entry. Shi et al.
describe 3 subpopulations of CD31+ thymic endothelial cells based
on their expression of Ly6C and P-selectin (73). Thymic portal
endothelial cells (TPEC) were identified as Ly6C−P-selectin+ and
were found to be enriched in vessels at the CMJ, with ~60% of
CD31+ vessels at the CMJ found to contain TPEC (73). Importantly,
TPEC are selectively reduced inmice lacking LTbR either in all cells,
or in models were LTbR is deleted specifically on endothelial cells
using a endothelial-specific Cre mouse model (Tie2Cre) crossed with
LTbRFlox mice, to generate LTbREndo mice (49, 73). Loss of TPEC in
these mice is accompanied with a significant reduction in the
number of early T-cell progenitors (ETP) within the thymus,
indicating a T-cell progenitor homing/colonization defect (73, 74).
Despite reduced ETP in the thymus of LTbR-deficient mice,
thymocyte development is rescued by compensatory expansion of
DN3 thymocytes which may expand due to the increased niche
availability (69, 74). Interestingly, levels of ICAM-1 and VCAM-1
were noticeably reduced in thymic endothelial cells from LTbR-
deficient mice, a finding consistent with a previous study showingFrontiers in Immunology | www.frontiersin.org 8that inhibition of ICAM-1 or VCAM-1 reduces thymus homing of
progenitor cells (67, 74). The localization of TPEC at the CMJ and
reduced ETP strong supports the proposed role of these cells in
regulating progenitor entry (73, 74). Interestingly, in addition to a
requirement for LTbR in the development of TPEC, absence of ab-
T-cells (as seen in TCRa−/− mice) also significantly reduced the
TPEC population, suggesting that provision of LTbR ligands by SP
thymocytes may act as part of a crosstalk mechanism between
thymocytes and endothelial cells to regulate development of the
latter (73).
Thymocyte Development
In addition to regulating the entry of lymphoid progenitor cells,
thymic endothelial cells have also been shown to regulate the
development of downstream thymocyte populations. For example,
Kit ligand (KitL) is a key regulator of early thymocyte proliferation
and differentiation (75), with membrane-bound KitL (mKitL) being
expressed by both cTEC and vascular endothelial cells found within
the cortex (76). Deletion of mKitL specifically on endothelial cells
(using Tie2CrePDGFRbCre endothelial specific mice) resulted in a
significant reduction in the frequencies of both ETP and DN1
thymocytes (76). In thymus sections, while DN1 thymocytes are in
close proximity to mKitL producing endothelial cells (76),
endothelial-derived mKitL was dispensable for T-cell
development, suggesting the involvement of additional mKitL
producing cells, such as cTEC, in control of ETP/DN1
progenitors (76). Interestingly it has been found that this mKitL-
c-Kit interaction is bi-directional, with mKitL signaling leading to
increased endothelial cell proliferation and thus endothelial mKitL
is essential in both ETP and endothelial cell regulation (77).
In addition to regulating the thymic entry, endothelial cells also
play a key role in regulating the egress of mature thymocytes from
the thymus into the blood (Figure 2). As discussed previously, the
sphingosine-1-phosphate (S1P) pathway is an essential mechanism
regulating egress of mature thymocytes from the adult thymus (78).
Maintenance of localized intrathymic levels of S1P is important to
ensure optimal egress and as such this is regulated by the balance of
production or inhibition of S1P by particular cell types in the
thymus. Endothelial cells have the capacity to achieve this by their
expression of particular enzymes or transport molecules allowing
them to influence the S1P gradient. For example, S1P lyase is one
particular regulator of this process, and as well as being expressed by
thymic mesenchymal cells, endothelial-specific expression of S1P
lyase is also essential for egress (39, 42). Furthermore, endothelial
cells express lipid phosphate phosphatase 3 (LPP3), a class of S1P-
degrading enzyme which dephosphorylates S1P (79). Much like S1P
lyase, its role in thymocyte egress is to help maintain low levels of
S1P, but unlike S1P lyase this process is not irreversible, as LPP3
works to dephosphorylate S1P reverting it to sphingosine which is
inactive to S1P1 (42, 79, 80). By deleting LPP3 in various cell types
in the thymus, Breart et al. demonstrated the essential role of this
enzyme in regulating thymocyte egress (79). Cell specific deletion of
Lpp3 through use of VE-CadherinCre to target endothelial cells
resulted in the intrathymic accumulation of mature SP thymocytes
suggesting a block in thymocyte egress (79). Interestingly deletion of
Lpp3 in TEC using K14Cre also caused an intrathymic accumulation,February 2021 | Volume 12 | Article 634367
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regulating thymocyte egress via manipulating/maintaining the
S1P gradient (79).
The expression of these two enzymes are examples of how
endothelial cells can downmodulate levels of S1P. However,
endothelial cells may also directly contribute to S1P availability
by virtue of their expression of the S1P transporter spinster
homolog 2 (Spns2) (81). Deletion of Spsn2 in endothelial cells
using a Tie2Cre crossed to Spsn2Flox mouse model resulted in the
intrathymic accumulation of SP thymocytes and reduced T-cell
numbers in the periphery, indicating a severe T-cell egress defect
(81). Follow up studies to understand these mechanisms in
light of the more recent endothelial population definitions
would significantly aid our understanding of how endothelial
cells regulate egress via the S1P pathway. For instance,
the localization of TPEC at the CMJ would make them an
attractive candidate to regulate T-cell egress via these
mechanisms. Perhaps in line with this, in the LTbREndo mouse
model which have a T-cell progenitor homing defect, there is also
clear indication that thymic egress is also LTbR-endothelial
dependent (49). Thus, LTbREndo mice exhibit an intrathymic
accumulation of mature thymocytes at a similar magnitude as
seen in the germline LTbR-deficient mouse thymus (48, 51). As
stated previously, these mice lack TPEC, suggesting these cells
regulate both entry and exit of T-cell populations in an LTbR
dependent manner (51, 73, 74). Interestingly, this endothelial-
regulated stage of egress was restricted to the PVS-entry step, the
penultimate step in the process of cells leaving the thymus (29,
39, 72, 82). Moreover, short-term FTY720 treatment prevents
entry of mature T-cell in the PVS which may suggest that this
process is S1P dependent; however; the exact mechanisms by
which endothelial cells regulate thymus egress in an LTbR-
dependent process remains unclear.
It has also been suggested that a thymus:blood barrier exists
in the thymus (83). However, this idea is at odds with the fact
that many of the vessels within the thymus function to allow
the trafficking of progenitors and mature T-cells into and out
of the thymus. Heterogeneity amongst thymic blood vessels
indicates that different vessels have different permeabilities and
provides evidence of how a thymus:blood barrier may be
present while also serving as entry and exit points of the
thymus. It has been shown that all cortical vessels express
Cld5 but only half of the blood vessels in the medulla and CMJ
express Cld5 (84). Thymus sections of mice injected
intravenously with a biotin tracer revealed that the biotin
tracer leaked into the medulla via Cld− vessels whereas little
penetration was found around Cld5+ vessels (84). The
importance of Cld5 expression by cortical vasculature in
maintaining their impermeable status was highlighted in
experiments where Cld5 deletion led to cortical vessels
becoming leaky (84). It is likely the leaky nature of medullary/
CMJ vessels aids entry/exit of trafficking cells, consistent with these
vessels being located at/near the CMJ. This is supported by
findings of accumulations of mature thymocytes within the PVS
of Cld5− vessels and also by IV injection of tetramethylrhodamine-
conjugated S1P which was found to leak into the medulla inFrontiers in Immunology | www.frontiersin.org 9thymus sections of injected mice likely contributing to the S1P-
gradient required for thymus egress (84).
TEC Regulation by Thymic Endothelium
Endothelial cells have also been reported to regulate TEC in the
steady-state and during thymus regeneration. For example, Choi
et al. showed that via Tie2Cre mediated deletion of plexinD1 on
endothelial cells, thymus lobes displayed reorganization of
vasculature, with a significant increase of vessels in the
subcapsular zone and a corresponding disruption of medulla
localization, where medullary areas were found at the subcapsular
zone and fused with the capsule (85). Thus, plxnd1 expression by
thymic endothelial cells influences medullary formation within the
thymus (85). Upon damage via total body sublethal irradiation,
endothelial cells upregulate their production of bone
morphogenetic protein 4 (BMP4) which in turn upregulates
Foxn-1 expression in TEC, leading to increased expression of
downstream Foxn-1 targets such as delta-like ligand 4 (DLL4)
which are involved in TEC development, maintenance and
regeneration (86). This process is essential for optimal thymus
regeneration as blocking BMP using a pan BMP inhibitor
significantly impairs thymus repair (86). Interestingly, thymic
endothelial cell regulation of TEC and thymus recovery may
have therapeutic implications. Indeed, intravenous
administration of thymic endothelial cells that were expanded in
vitro (exEC) significantly improved thymus regeneration upon
damage with exEC reported to home to the thymus and potentially
exert this effect intrathymically (86). Further therapeutic potential
was established by a follow up study which found that
administering zinc increased the thymus regeneration and TEC
proliferation (87). Zinc supplementation simultaneously increased
endothelial cell numbers and induced increased expression of
BMP4 to significantly promote thymic reconstitution (87).
Interestingly, the zinc receptor GPR39 is expressed at steady-
state, but expression is increased upon damage suggesting
endothelial cells increase their receptiveness to zinc to enhance
their regeneration function (87).
Thymic Endothelium Regulation by TEC
In a similar fashion to bi-directional cellular crosstalk reported to
occur between thymic epithelium and mesenchyme, and thymic
epithelium and thymocytes, crosstalk may also operate between
epithelial and endothelial compartments. Vascular endothelial
growth factor (VEGF) is a key regulator of vascular development
and has been shown to be key in the thymus endothelial
development during neonatal development but is largely
dispensable in adults (88). Thymic epithelial cells, while being
influenced by thymic endothelial cells during their development,
maintenance and regeneration as described above, may themselves
have a reciprocal role in regulating endothelial cells. Muller et al.
showed that by targeting deletion of VEGF-A to thymic epithelial,
thymus vasculature was significantly altered. Deleting VEGF-A on
TEC resulted in hypovascularization and disruption of the normal
vascular distribution within the thymus, highlighting VEGF-A as an
epithelial growth factor which is required for normal thymus
vasculature development (89). Inhibition of VEGF in neonatalFebruary 2021 | Volume 12 | Article 634367
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within the thymus (90, 91). Additionally, loss of Foxn-1 expression
in Foxn-1D/D embryonicmice (homozygous for hypomorphic Foxn-
1D allele; model with less severe phenotype than foxn-1null mice)
causing significantly reduced VEGF expression which resulted in
significant changes to the vasculature within the thymus including
reduced vessel integrity and disorganized patterning/distribution
(92). These data are interesting as they emphasize how epithelial
cells support the development of the vasculature and other studies
demonstrate that normal vascular development is essential for the
support of thymic epithelial cells, highlighting a level of cross-talk
between the two populations to ensure the optimal development of
each compartment.NON-EPITHELIAL STROMA AND AGE-
RELATED THYMIC INVOLUTION
The thymus undergoes drastic age-associated involution which
impacts immune function (93, 94). With age, the thymus
becomes smaller, T-cell output is diminished and stromal
microenvironments change (93, 95, 96). With regards to the
latter, a considerable amount of aged thymic space is composed
of adipose tissue, which occurs alongside a reduction in the area and
organization of the TEC compartment due to cTEC and mTEC loss
(97, 98). These impaired cTEC and mTEC compartments are
associated with significantly reduced thymocyte development and
output in aged thymus (97). In contrast, how thymic NES
populations change with age is less well documented, and so little
is known about how changes in these cell types may relate to
declining age-related thymus function. Relevant to this, fibroblasts
represent an increasing stromal population within the aging thymus
(95). While the reasons for this are not fully clear, it has been
suggested that it may occur as a result of increased epithelial-
mesenchyme transitioning (EMT) occurring during aging, which
causes increased fibroblasts, which may then also transition further
into adipocytes (99). Consistent with this, thymicmesenchymal cells
possess the ability to differentiate into adipocytes from
thymosphere-forming cells (37).
Interestingly, it has also been shown that adipocytes accumulate
in the PVS within the aged thymus (100). While the potential
functional significance of this is not clear, it raises interesting
questions, including how might increased adipocyte frequency at
this site influence thymus entry and/or emigration? As the PVS is a
site of mature thymocyte egress, alterations in these regions may
contribute to any reduced thymic output already caused by
thymocyte development defects linked to reduced/altered TEC. In
addition, it has been shown that thymocyte development is
supported by NES, for example mKitL production by
endothelium, or IL-7 presentation by mesenchymal ECM
components (22, 76). Thus, age-related alterations in NES may
impair thymopoiesis by limiting these processes. Interestingly, IL-7
is reduced with age and may contribute to reduced thymopoiesis
seen with aging (101). Also, while IL-7 is a TEC product (102) it
may be interesting to consider whether changes in thymic
mesenchyme in an aged thymus result in less effectiveFrontiers in Immunology | www.frontiersin.org 10presentation of this cytokine, as compared to their counterparts in
a younger thymus. In sum, it is important that as our understanding
of the characteristics and functions of the NES compartment
continues to expand in the steady state thymus, it should also be
applied to investigations of disease and aging.CONCLUDING REMARKS
The non-autonomous nature of intrathymic T-cell development,
and the subsequent requirement for thymocyte-extrinsic signals
from thymic stromal cells, is well established. Of the diverse
stromal cell types that contribute to cortical and medullary
microenvironments, thymic epithelial cells (TEC) have been
the predominant focus of study over many years. This is likely
due at least in part to their fundamental importance in shaping
the functional properties of ab-T-cells produced in the thymus.
Indeed, TEC populations control MHC restriction and
determine the specificity of the T-cell receptor repertoire by
both positive and negative selection events. In addition to the
importance of TEC biology, non-epithelial stromal cells (NES)
have also been a focus of study, but to a significantly lesser extent.
However, NES such as mesenchyme and endothelium have been
implicated in key aspects of thymus function. For mesenchyme,
their influence on T-cell development can operate by multiple
mechanisms. Thus, mesenchyme-derived signals can either
target developing thymocytes directly (22, 23), or indirectly by
regulating TEC function (14, 16, 32). This fits well with the
nature of the thymus epithelial-mesenchymal organ and
highlights the need for further study of NES-TEC and NES-
thymocyte interactions. Relevant to this, the recent identification
of newly defined mesenchyme subsets within NES should
facilitate a better understanding of their importance.
For endothelial populations within NES, growing evidence
supports their importance in controlling cellular trafficking into
and out of the thymus. As the efficacy of these processes can act as
rate-limiting steps in T-cell production (51, 65, 67, 74, 76, 79), again
a better understanding of the endothelial subsets that contribute to
intrathymic vessels for both thymus entry and exit is an important
goal of future research. Finally, that endothelial cells also play a role
in the regeneration of the thymus following damage (86) opens a
new chapter in the relevance of these cells in controlling thymus
function in health and disease.AUTHOR CONTRIBUTIONS
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